Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Prepaid Assets (2016 - 2025)

Corcept Therapeutics' Prepaid Assets history spans 10 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 67.54% year-over-year to $7.1 million; the TTM value through Dec 2025 reached $7.1 million, down 67.54%, while the annual FY2025 figure was $7.1 million, 67.54% down from the prior year.
  • Prepaid Assets for Q4 2025 was $7.1 million at Corcept Therapeutics, down from $21.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $21.9 million in Q4 2024 and bottomed at $5.9 million in Q4 2023.
  • The 5-year median for Prepaid Assets is $12.9 million (2022), against an average of $13.5 million.
  • The largest annual shift saw Prepaid Assets soared 271.98% in 2024 before it plummeted 67.54% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $10.3 million in 2021, then skyrocketed by 59.22% to $16.4 million in 2022, then crashed by 64.19% to $5.9 million in 2023, then skyrocketed by 271.98% to $21.9 million in 2024, then crashed by 67.54% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Prepaid Assets are $7.1 million (Q4 2025), $21.9 million (Q4 2024), and $18.9 million (Q3 2024).